1. Home
  2. RNW vs SRPT Comparison

RNW vs SRPT Comparison

Compare RNW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$6.18

Market Cap

2.2B

Sector

Utilities

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$16.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
SRPT
Founded
2011
1980
Country
United Kingdom
United States
Employees
4336
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
RNW
SRPT
Price
$6.18
$16.77
Analyst Decision
Hold
Hold
Analyst Count
1
29
Target Price
$7.00
$25.85
AVG Volume (30 Days)
1.2M
3.1M
Earning Date
06-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.99
Revenue
N/A
$2,198,237,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$11.50
N/A
P/E Ratio
$14.63
$5.61
Revenue Growth
N/A
15.58
52 Week Low
$4.39
$14.68
52 Week High
$8.24
$25.32

Technical Indicators

Market Signals
Indicator
RNW
SRPT
Relative Strength Index (RSI) 52.42 51.19
Support Level $5.95 $15.55
Resistance Level $6.33 $18.16
Average True Range (ATR) 0.18 0.82
MACD 0.00 0.04
Stochastic Oscillator 67.86 68.81

Price Performance

Historical Comparison
RNW
SRPT

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: